The Global Preclinical Imaging Market growth is driven by innovation in imaging modalities
The Global Preclinical Imaging Market is estimated to be valued at US$ 4.25 BN in 2024 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024 to 2031.
Key Takeaways:
Key players operating in the Global Preclinical Imaging are Bruker Corporation, Siemens A.G., General Electric (GE), TriFoil Imaging, PerkinElmer, Inc., VisualSonics Inc. (Fujifilm), Inc., Mediso Ltd., Agilent Technologies, MILabs B.V., MR Solutions, and Molecubes.
The increasing Research and Development expenditure in pharmaceutical and biotechnology industries is driving the Preclinical Imaging Market Demand techniques for drug discovery and development. Moreover, advancement in imaging modalities such as high-resolution micro-MRI and micro-CT, and multimodal imaging systems is fueling the market growth. Major players are focusing on geographical expansion plans across emerging markets to leverage market opportunities.
Get More insights on Preclinical Imaging Market
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian